Evelo Biosciences

(OTC) EVLO

Current Price$0.00

Market CapN/A

Since IPO (2018)-100%

5 Year-100%

1 Year-100%

1 Month+0%

Evelo Biosciences Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$82.35M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-19.74 (Low)

Dividend

$0.00

Beta (Volatility)

-19.74 (Low)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Dividend

$0.00

Beta (Volatility)

-19.74 (Low)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

EVLO News

Will the Gut Microbiome Change Medicine? Wall Street Isn't Convinced.

Maxx ChatskoSep 17, 2019

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Evelo Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Simba Gill, PhD, MBA

Website

www.evelobio.com

Headquarters

Cambridge, MA 02139, US

EVLO Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

18.98M

Volume

Avg. Volume

426.746

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$108.47M

EBITDA

-$106.35M

Operating Cash Flow

-$101.24M

Capital Expenditure

-$622.00K

Free Cash Flow

-$101.86M

Cash & ST Invst.

$47.94M

Total Debt

$51.14M

Evelo Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$793.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$12.36M

+59.5%

EBITDA

-$11.05M

+62.0%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Net Cash

-$16.69M

-217.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$33.95M

+135.0%

Return on Assets

-1.78%

N/A

Return on Invested Capital

-2.08%

N/A

Free Cash Flow

-$10.46M

+53.7%

Operating Cash Flow

-$10.41M

+53.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

INFIQInfinity Pharmaceuticals, Inc.

INFIQInfinity Pharmaceuticals, Inc.$0.00+0.00%

LIFSLife Stem Genetics Inc.

LIFSLife Stem Genetics Inc.$0.00+0.00%

ARDSAridis Pharmaceuticals, Inc.

ARDSAridis Pharmaceuticals, Inc.$0.00+0.00%

STABStatera Biopharma, Inc.

STABStatera Biopharma, Inc.$0.00+0.00%

TRVNTrevena, Inc.

TRVNTrevena, Inc.$0.00+0.00%

ICCTiCoreConnect Inc.

ICCTiCoreConnect Inc.$0.00+0.00%

HSTCHST Global, Inc.

HSTCHST Global, Inc.$0.70+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

FFord Motor Company

FFord Motor Company$17.44+0.05%

NOKNokia

NOKNokia$14.84-0.03%

PLTRPalantir Technologies

PLTRPalantir Technologies$156.54+0.09%

TAT&T

TAT&T$24.80-0.00%

HPEHewlett Packard Enterprise

HPEHewlett Packard Enterprise$43.04+0.13%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.92-0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$84.56+0.01%

Questions About EVLO

What is the current price of Evelo Biosciences?

Evelo Biosciences is trading at $0.00 per share.

What is the 52-week range for Evelo Biosciences?

Over the past 52 weeks, Evelo Biosciences has traded between $0.00 and $0.00.

How much debt does Evelo Biosciences have?

As of the most recent reporting period, Evelo Biosciences reported total debt of $51.14M.

How much cash does Evelo Biosciences have on hand?

Evelo Biosciences reported $47.94M in cash and cash equivalents in its most recent financial results.

What is Evelo Biosciences’s dividend yield?

Evelo Biosciences does not currently have a dividend yield.

Evelo Biosciences

Evelo Biosciences Financials at a Glance

EVLO News

Will the Gut Microbiome Change Medicine? Wall Street Isn't Convinced.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Evelo Biosciences

EVLO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Evelo Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About EVLO

What is the current price of Evelo Biosciences?

What is the 52-week range for Evelo Biosciences?

How much debt does Evelo Biosciences have?

How much cash does Evelo Biosciences have on hand?

What is Evelo Biosciences’s dividend yield?

Premium Investing Services